<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00885053</url>
  </required_header>
  <id_info>
    <org_study_id>ADIPOMEGA</org_study_id>
    <nct_id>NCT00885053</nct_id>
  </id_info>
  <brief_title>Fish Oil and Inflammation in Overweight Subjects</brief_title>
  <acronym>ADIPOMEGA</acronym>
  <official_title>The Effect of Acute and Short-term Intervention With Fish Oil on Overweight Subjects - Focus on Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg Universitetshospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aalborg Universitetshospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effects of acute and short-term intervention with
      fish oil on inflammatory markers in overweight subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Being overweight is associated with metabolic syndrome, cardiovascular disease, and diabetes
      mellitus (type 2). Adipose tissue can be regarded as an active organ, which produces an array
      of inflammatory mediators. This creates a state of chronic low-grade inflammation.
      Inflammation has been proven to be a key element in the development of atherosclerotic
      plaques.

      The marine n-3 polyunsaturated fatty acids (PUFAs) have beneficial effects on cardiovascular
      disease. These effects are partly attributed to the anti-inflammatory effect of the n-3
      PUFAs.

      Previous studies have shown an anti-inflammatory effect of n-3 PUFAs in overweight subjects,
      but the studies have been conducted with a high daily dose of n-3 PUFA. We want to examine
      the effect of a lower dose of 1 g n-3 PUFA/day (the dose recommended by the Danish Heart
      Foundation).

      The study is randomized, placebo-controlled and double blinded. Fifty subjects aged 30 - 75
      years (postmenopausal women; waist circumference &gt; 80 cm and men; waist circumference &gt; 94
      cm) will be included.

      Blood samples and fatty tissue biopsies will be collected at baseline, after 1 day and after
      6 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the effect of 1 g/day of n-3 polyunsaturated fatty acids on inflammatory markers</measure>
    <time_frame>After 1 day and after 6 weeks intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess effect of 1 g n-3 polyunsaturated fatty acids (daily dose) on the fatty acid profile of plasma, leucocytes and adipose tissue.</measure>
    <time_frame>After 1 day and 6 after weeks of intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the effect of 1g n-3 polyunsaturated fatty acids (daily dose) on the gene expression profile (mRNA) - especially genes involved in encoding the inflammatory response.</measure>
    <time_frame>After 1 day and 6 after weeks of intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Fish oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Olive oil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>fish oil</intervention_name>
    <description>Capsules. Approximately 1000 mg n-3 PUFA daily. One day + 6 weeks</description>
    <arm_group_label>Fish oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>olive oil</intervention_name>
    <description>Capsules. Approximately 1 g olive oil daily. One day + 6 weeks</description>
    <arm_group_label>Olive oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Waist circumference ≥ 80 cm (females) or ≥ 94 cm (males)

          -  Postmenopausal (females)

        Exclusion Criteria:

          -  Daily intake of fish oil capsules

          -  Daily intake of NSAIDs

          -  HbA1c ≥ 8%

          -  Serum creatinine ≤ 30 mL/min

          -  Chronic inflammatory disease

          -  Other serious illness

          -  Inability to informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aalborg Hospital, Aarhus University Hospital</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008 Dec;29(24):2959-71. doi: 10.1093/eurheartj/ehn387. Epub 2008 Sep 5. Review.</citation>
    <PMID>18775919</PMID>
  </reference>
  <reference>
    <citation>Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007 Oct 23;116(17):1942-51.</citation>
    <PMID>17965405</PMID>
  </reference>
  <reference>
    <citation>Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 Mar 5;105(9):1135-43. Review.</citation>
    <PMID>11877368</PMID>
  </reference>
  <reference>
    <citation>Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1505S-1519S. doi: 10.1093/ajcn/83.6.1505S. Review.</citation>
    <PMID>16841861</PMID>
  </reference>
  <reference>
    <citation>Schmidt EB, Arnesen H, de Caterina R, Rasmussen LH, Kristensen SD. Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety. Thromb Res. 2005;115(3):163-70. Review.</citation>
    <PMID>15617737</PMID>
  </reference>
  <reference>
    <citation>Schmidt EB, Arnesen H, Christensen JH, Rasmussen LH, Kristensen SD, De Caterina R. Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendations. Thromb Res. 2005;115(4):257-62. Review.</citation>
    <PMID>15668184</PMID>
  </reference>
  <reference>
    <citation>Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab. 2007 Jan;9(1):70-80.</citation>
    <PMID>17199721</PMID>
  </reference>
  <reference>
    <citation>Kris-Etherton PM, Harris WS, Appel LJ; AHA Nutrition Committee. American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):151-2. Review.</citation>
    <PMID>12588750</PMID>
  </reference>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2009</study_first_submitted>
  <study_first_submitted_qc>April 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2009</study_first_posted>
  <last_update_submitted>January 25, 2010</last_update_submitted>
  <last_update_submitted_qc>January 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>Trine Madsen / MD</name_title>
    <organization>Department of Cardiology, Aalborg Hospital, Aarhus University Hospital, Denmark</organization>
  </responsible_party>
  <keyword>Inflammation</keyword>
  <keyword>Fatty acids, Omega 3</keyword>
  <keyword>Leukotrienes</keyword>
  <keyword>Adiponectin</keyword>
  <keyword>Adipose tissue</keyword>
  <keyword>RNA, Messenger</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

